The utility of ancillary tests in monitoring cutaneous melanoma patients to detect visceral metastasis

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 12, 2015, Pages 2493-2495

  Ferreres, J R ^a   Marcoval, J ^a   Fodge, K ^a   De Olza, M Ochoa ^b   Vinals A ^a   Fabra, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD ANALYSIS; CANCER RECURRENCE; CLINICAL EXAMINATION; CUTANEOUS MELANOMA; HUMAN; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; RADIATION EXPOSURE; THORAX RADIOGRAPHY; ULTRASOUND; VISCERAL METASTASIS; ABDOMINAL TUMOR; ADULT; AGED; BLOOD; CANCER STAGING; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HEALTH SURVEY; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIOGRAPHY; SECONDARY; SKIN TUMOR; SURVIVAL RATE; THORAX TUMOR;

LACTATE DEHYDROGENASE;

ABDOMINAL NEOPLASMS; ADULT; AGED; FEMALE; HUMANS; LACTATE DEHYDROGENASES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; RADIOGRAPHY; SKIN NEOPLASMS; SURVIVAL RATE; THORACIC NEOPLASMS; ULTRASONOGRAPHY;

EID: 84959326336     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12602     Document Type: Letter

References (10)

1. Shumate CR, Urist MM, Maddox WA,. Melanoma recurrence surveillance. Patient or physician based? Ann Surg 1995; 221: 566-569.
2. Hofmann U, Szedlak M, Rittgen W, et al,. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer 2002; 87: 151-157.
3. Garbe C, Paul A, Kohler-Spath H, et al,. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003; 21: 520-529.
4. Francken AB, Bastiaannet E, Hoekstra HJ,. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol 2005; 6: 608-621.
5. Meyers MO, Yeh JJ, Frank J, et al,. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging. Ann Surg Oncol 2009; 16: 941-947.
6. Romano E, Scordo M, Dusza SW, et al,. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol 2010; 28: 3042-3047.
7. Rychetnik L, McCaffery K, Morton R, Irwig L,. Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psychooncology 2013; 22: 721-736.
8. Holterhues C, van de Poll-Franse LV, de Vries E, Neumann HA, Nijsten TE,. Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population. J Eur Acad Dermatol Venereol 2012; 26: 1389-1395.
9. Rueth NM, Xing Y, Chiang YJ, et al,. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies Ann Surg 2014; 259: 1215-1222.
10. Mathews JD, Forsythe AV, Brady Z, et al,. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013; 346: f2360.